Intellectual Property (IP) workshop: "Leveraging IP in a Globalised World"

Dr Richard Jennings - moderator
Director of Technology Transfer and Consultancy Services
Cambridge Enterprise

Richard is Director of Technology Transfer and Consultancy Services, responsible for two core areas of Cambridge Enterprise Limited's activities. He is a board member of both Cambridge Enterprise Limited and its wholly owned consultancy company, Cambridge University Technical Services Limited (CUTS). Richard is also Chair of the board of Cambridge Manufacturing Industry Links Ltd, the Institute for Manufacturing's knowledge transfer company. Richard has an extensive track record of establishing mutually beneficial university- industry collaborations and commercialising University-derived intellectual property through consultancylicensing and spin-off companies. Richard has a D. Phil in Chemistry from the University of Sussex.

Dr Devanand Crease
Partner
Keltie - Patent and Trademark Attorneys

Dev is a partner and leads the Bioscience and Medical Technologies team at Keltie. He has worked in the life science field for over ten years and represents biotech and medical technology clients based in the UK, US and Asia.

Dev specialises in providing strategic advice and support for emerging companies in the fields of stem cells, genomics, epigenetics, medical devices, protein biochemistry and molecular diagnostics. He has particular experience working with academic research groups and developing IP strategies to support commercialisation of technology from the university sector. He advises on contentious and non-contentious matters, due diligence, freedom to operate as well as drafting and prosecution of patent applications.

Dev has a first degree in biochemistry from University College London. He went on to undertake a Ph.D. in developmental biology at the Gurdon Institute in Cambridge in the laboratory of Sir John Gurdon.

Dr Jennifer Davis
Herchel Smith College Lecturer
Centre for Intellectual Property and Information Law, University of Cambridge.

Dr. Jennifer Davis is the Herchel Smith College Lecturer in Intellectual Property Law and a member of the Centre for Intellectual Property and Information Law, University of Cambridge. She is also a Fellow of Wolfson College, Cambridge. She is the author of Intellectual Property Law (OUP: 2008) and with Tanya Aplin, Intellectual Property: Text, Cases and Materials (OUP: 2009). Together with Lionel Bently and Jane Ginsburg, she edited: Trade Marks and Brands: An Interdisciplinary Critique (CUP: 2008) and Copyright and Piracy (forthcoming, CUP: 2010). She has a particular interest in trade mark law, branding, unfair competition and personality rights and has published extensively on these topics. Before joining the Faculty of Law, Dr Davis practiced as a solicitor specializing in intellectual property litigation.

Dr Tim Fell
Chief Operating Officer
CellCentric

Following his D.Phil in semiconductor materials Tim migrated to the biological sciences in 1992 to work with DNA microarray pioneer Prof Ed Southern at Oxford University. In 1999 he co-founded Oxford Gene Technology (operations) Ltd where as Technical Director, and later as General Manager, he developed a DNA microarray fee-for-service business.

In 2002 UK anti-infective drug discovery company Arrow Therapeutics Ltd acquired the business and he joined the management team as Chief Technology Officer. In 2005 he spent a year with the London Technology Network as a Technology Consultant with a remit to stimulate collaboration between global business and the local academic research base before joining CellCentric as Chief Operating Officer in 2006. Tim has an MBA from the London Business School.

Dr Jason Pinto
VC
Amadeus Capital Partners

Jason is an associate at Amadeus Capital Partners, focused on the hardware and clean technology sectors. Amadeus invests in technology companies at every stage of development from seed to late stage in a broad diversity of industries including telecommunications, media, e-commerce, IT, software and medtech. Since joining Amadeus in 2006, Jason has worked on a number of investments for the firm and currently supports several portfolio companies including: Forth Dimension Displays, a UK based micro-display developer; Edgeware, which builds server systems for on-demand TV; Xelerated, a provider of network processors; Liquavista, which develops low power consumption high viewability electronic displays; and EnQii, which provides a managed service proposition to digital-out-of- home advertising networks.

Prior to Amadeus Jason was a lead member of a multidisciplinary research and development team at E Ink Corporation where he worked on commercialization of the worldʼs first electronic ink display. This display is currently deployed in a number odegrees in engineering and science.

Dr Ilian Iliev
Founder and CEO
CambridgeIP

Prior to CambridgeIP Ilian was provided strategy consultancy to global clients in the technology and professional services sector. He has advised on innovation policy in the UK, South Africa and Bulgaria. Ilian is an Associate Fellow at Chatham House (the Royal Institute of International Affairs), a regular contributor to the Licensing Executives Society and has published widely in both academic and business media on the topics of innovation finance, science-industry technology transfer, service sector innovation and technology policy. Prior to CambridgeIP Ilian was a co-founder of an award-winning medical diagnostics university startup, and a family business in the electrical industry.

CambridgeIP is an innovative provider of:IP strategy and patent-based intelligence to the technology sector in the UK and internationally. Clients include major corporations, VCs, technology consultancies and the public sector, with a presence in Cambridge, London, Boston, Houston and Geneva. The company has specific expertise in the Health and Life Science, Energy/CleanTech and Telecoms areas. CambridgeIP's research has been covered by Harvard Business Review and other industry media.

Keltie is a partnership of patent and trade mark attorneys, acting globally for great clients in all fields of commerce and technology, and also offers consulting services to IP owners